[1]
A. Akgül and N. S. Koç, “Severe Hypernatremia Associated with Intravenous Fosfomycin: A Preventable Adverse Effect in the Intensive Care Setting”, J Eur Int Med Prof, vol. 4, no. 1, pp. 41–42, Feb. 2026.